Possible Beneficial Effect of Dapagliflozin in Improvement of Dyspnea Scale (VAS and SA-NYHA Class) in Patients with Acute Decompensated Heart Failure (ADHF)
Heart failure (HF) is a condition in which the heart is unable to pump enough blood to meet the body's needs. Diuretics are the mainstay of acute heart failure therapy, especially intravenous loop diuretics. In this study, IV.furosemide (120mg/day) plus 10mg dapagliflozin tablet were used dail...
Saved in:
| Main Authors: | Hanna Jassim Dohei, Maitham Ali Al-Rikabi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
University of Thi-Qar
2024-12-01
|
| Series: | مجلة علوم ذي قار |
| Subjects: | |
| Online Access: | https://jsci.utq.edu.iq/index.php/main/article/view/1274 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of dapagliflozin on serum N‐terminal fragment-proB‐type natriuretic peptide level in patient with acute decompensated heart failure
by: Hanna Jassim Dohei, et al.
Published: (2025-03-01) -
Dynamics of uric acid concentration against the background of early dapagliflozin use in patients with acute decompensation of heart failure
by: Laura H. Sarieva, et al.
Published: (2024-01-01) -
Randomized trial to assess worsening renal function by adding dapagliflozin for acute decompensated heart failure
by: Shodai Kawanami, et al.
Published: (2025-06-01) -
Aquaretics Use in Acute Decompensated Heart Failure (ADHF) Patients: A Literature Review
by: Norman Sukmadi, et al.
Published: (2022-09-01) -
Strategy of selecting the scales of risk, prognosis, and disease severity in patients with acute decompensated heart failure
by: A. G. Arutyunov
Published: (2013-04-01)